Meeting Banner
Abstract #1443

Enhancement of the Lymphatic System Following Intravenous Administration of Ferumoxytol

Daniel F Young1,2, Surendranath Veeram Reddy1, Abhay Veeram Divekar 1, Sheena Pimpalwar1, Tarique Hussain1, and Joshua S Greer1
1Pediatrics, UT Southwestern, Dallas, TX, United States, 2Pediatrics, Children's Health Medical, Dallas, TX, United States


Lymphatic Imaging is increasingly important in the management of patients with Congenital Heart Disease. It is not known how the intravenous contrast agent ferumoxytol influences this imaging. This retrospective review of 120 patients suggests that intravenously given ferumoxytol rapidly enters the lymphatic system. The resultant shortening of T2 relaxation causes a degradation in T-2 weighted lymphangiography. Conversely, T1-weighted angiography shows clear depiction of the thoracic lymphatic duct immediately after ferumoxytol infusion. This enhancement depends on fasting status of the patient. The classic mechanism of macrophage uptake of iron oxide for MR lymphangiography does not explain the timing of these findings.

This abstract and the presentation materials are available to members only; a login is required.

Join Here